Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 7Unknown 5Terminated 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Thoracic 2Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 6Head and Neck Neoplasms 4Esophageal Neoplasms 4Adenocarcinoma Of Esophagus 4Esophageal Squamous Cell Carcinoma 3Breast Neoplasms 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Rectal Neoplasms 2Colonic Neoplasms 2Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC 1Stage IV EGFR Mutated Non-Small Cell Lung Cancer 1Prostatic Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Kidney Neoplasms 1Gliosarcoma 1Glioblastoma 1Colorectal Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Temozolomide 28Radiosurgery 19Radiotherapy 17Bevacizumab 12Magnetic Resonance Spectroscopy 9Radiation 6Erlotinib Hydrochloride 6Carboplatin 6Topotecan 5Nivolumab 5Mental Status and Dementia Tests 5Irinotecan 5Capecitabine 5pembrolizumab 4dabrafenib 4Trastuzumab 4Sunitinib 4Pemetrexed 4Ipilimumab 4Filgrastim 4Cyclophosphamide 4Aminolevulinic Acid 42,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 4cabozantinib 3Vorinostat 3TPI-287 3Specimen Handling 3Radiotherapy, Intensity-Modulated 3Methylphenidate 3Lomustine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Brain Neoplasms × Gefitinib × Clear all
NCT01310855 2017-05-31

Cediranib Maleate With or Without Gefitinib in Treating Patients With Recurrent or Progressive Glioblastoma

University College, London

Phase 2 Terminated
38 enrolled 8 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT01363557 2014-05-13

ARPEGE

Assistance Publique - Hôpitaux de Paris

Phase NA Terminated
1 enrolled
CNSThoracic

Brain Neoplasms, Lung Neoplasms

NCT00234442 2009-06-30

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

AstraZeneca

Phase 2 Terminated
47 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡